Sobi, Inc.
Waltham, MA
- UEI
- S2TUAPDB2971
- CAGE
- 7ZLC4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- H4GBVP9DGRL6
-
- SAM.gov registration date
- Physical address
- 77 CityPoint, 77 4th Ave #3, Waltham, MA 02451, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tegsedi | Veterans Integrated Service Network 10 (VHA) | $105,196 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Biogen U.s. Corporation | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
About the company
Sobi, Inc. is a foreign-owned, for-profit corporate entity that provides pharmaceuticals and drug products to the federal government through prime contract awards. The company specializes in rare disease treatments and has been registered in the System for Award Management (SAM.gov) since 2017.
Sobi, Inc. has been awarded firm fixed price contracts and calls to provide the drug TEGSEDI, used to treat polyneuropathy of hereditary transthyretin-mediated amyloidosis. These awards have primarily been issued by the Department of Veterans Affairs (VA) to support healthcare programs serving veterans. Most recently, Sobi, Inc. received a $105,195.60 contract call from the VA Veterans Health Administration's Veterans Integrated Service Network 10 for delivery of TEGSEDI to a facility in Bartlett, Tennessee. The company has also provided the drug ORFADIN through contract actions with the VA. Sobi, Inc.'s contract awards have not utilized any set-aside designations.
Under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), Sobi, Inc. holds two major contract vehicles facilitating orders from federal agencies. The first is a multiple award schedule contract awarded by the VA Veterans Health Administration with a potential value of $78 million through July 2025. The second is a single award blanket purchase agreement issued by the VA National Acquisition Center, valued at up to $11.75 million covering the period of October 2021 to September 2024. This BPA enabled the previously mentioned task order for TEGSEDI delivery to Bartlett, Tennessee. Both the FSS schedule contract and BPA agreement allow the VA to procure pharmaceuticals such as TEGSEDI and ORFADIN from Sobi, Inc. to aid in treatment and care for veterans.
Quick answers
Is Sobi, Inc. registered in SAM.gov?
Yes. Sobi, Inc.'s SAM.gov registration is active through February 20, 2027.
What is Sobi, Inc.'s CAGE code?
Sobi, Inc.'s CAGE code is 7ZLC4, and its Unique Entity ID (UEI) is S2TUAPDB2971.
Which contract vehicles does Sobi, Inc. hold?
Sobi, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Sobi, Inc.'s most recent federal award?
Sobi, Inc.'s most recent federal contract award is Tegsedi (36C25022N0640), from Veterans Integrated Service Network 10 (VHA), on June 15, 2022.
On GovTribe
See Sobi, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors